共 7 条
[1]
Activity of bisphosphonates against Trypanosom brucei rhodisiense. Martin MB, Sanders JM, Kendric H, et al. Journal of Medicinal Chemistry . 2002
[2]
Radical cure experimental cutaneous Leishmaniasis by the bisphosphonate pamidronate. Rodriguez N, Bailey BN, Martin MB, et al. The Journal of Infectious Diseases . 2002
[3]
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Fisher JE, Rogers MJ, Halasy JM, et al. Proceedings of the National Academy of Sciences of the United States of America . 1999
[4]
Clo dronateandliposome encapsulatedclodronateareme tabolizedtoatoxicATPanalogue,adenosine5′（be ta,gamma dichloromethylene）triphosphate,bymam maliancellsinvitro. FrithJC,MonkkonenJ,BlackburnGM ,etal. JBoneMinerRes . 1997
[5]
In vivo effects of bisphosphonantes on the osteoclast mevalonate pathway. Fisher JE, Rodan GA, Reszka AA. The Journal of Endocrinology . 2000
[6]
Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages. Luckman SP, Coxon FP, Ebetino FH, et al. Journal of Bone and Mineral Research . 1998
[7]
Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates. van Beek E, Pieterman E, Cohen L, et al. Biochemical and Biophysical Research Communications . 1999